Loading clinical trials...
Loading clinical trials...
Sleep Disturbances as a Non-traditional Risk Factor in CKD-Wrist Actigraphy
To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovascular function as measured by C-reactive protein in the blood. The study will explore the role of decreased sleep time or decreased sleep quality as a non-traditional risk factor for the progression of CKD and for the development of cardiovascular disease in CKD.
Age
21 - 74 years
Sex
ALL
Healthy Volunteers
Yes
The University of Chicago
Chicago, Illinois, United States
Start Date
November 1, 2007
Primary Completion Date
October 1, 2010
Completion Date
October 1, 2010
Last Updated
September 5, 2013
353
ACTUAL participants
Lead Sponsor
University of Chicago
Collaborators
NCT07241390
NCT06926660
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06717698